Selection Of Theaflavin 2B As a Potential HSP90 Antagonist Semi-rigid Ligand Docking Analysis
S. A. Akinsehinwa, O. Medayedupin
This study evaluates theaflavin 2B as a potential HSP90 inhibitor through computational docking, showing higher binding affinity than standard inhibitors.
bioRxiv · Jun 24, 2022 · PreprintPharmacology & Toxicology